Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma
A clinical trial evaluating the combination of transarterial chemoembolization (TACE) with targeted immunotherapy for unresectable hepatocel…
-
CLINICAL_TRIALS research · 2024-08-05Clinical Trial Update: Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach（Radiogenomics-Liver）
This clinical trial is exploring the relationship between imaging features and the tumor microenvironment in liver cancer using a radiogenom…
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis [Phase 1]
Phase 1 trial evaluating defined green tea catechin extract to prevent liver cancer in people with cirrhosis; the study is currently active …
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Combined Locoregional Treatment With Immunotherapy for Unresectable HCC. [Phase 1]
Phase 1 trial update evaluating combined locoregional treatment with immunotherapy for unresectable hepatocellular carcinoma; the study is c…
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection [Phase 2]
Phase 2 clinical trial update on adjuvant therapy with adebrelimab and apatinib for hepatocellular carcinoma at high risk of recurrence afte…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients [Phase 2]
A Phase 2 clinical trial evaluating transarterial chemoembolization (TACE) in combination with camrelizumab for hepatocellular carcinoma; th…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial investigates cryoablation combined with a PD-1 antibody and bevacizumab for hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC [Phase 2]
A Phase 2 clinical trial evaluating mFOLFOX7 plus camrelizumab and apatinib for advanced hepatocellular carcinoma (CNLC Stage III) is curren…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer [Phase 1]
Phase 1 clinical trial update for BST02 targeting locally advanced hepatocellular carcinoma (liver cancer).
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma [Phase 1, Phase 2]
A pharmacogenetic study of Sorafenib in Egyptian patients with hepatocellular carcinoma is planned as Phase 1/Phase 2 and is currently recru…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: Neoadjuvant SBRT Combined With Lenvatinib and Pucotenlimab for Resectable Hepatocellular Carcinoma [Phase 2]
Update on a Phase 2 clinical trial evaluating neoadjuvant SBRT combined with lenvatinib and pucotenlimab for resectable hepatocellular carci…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
A multicenter study in China is investigating features of the gut microbiota in patients with several chronic diseases and is currently recr…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients [Phase 2]
A Phase 2 pilot study is evaluating cannabis oil in patients with untreatable hepatocellular carcinoma (liver cancer). The trial is currentl…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies [Phase 1]
Phase 1 clinical trial evaluating ablation in combination with lenvatinib and anti-PD-1 antibodies for hepatocellular carcinoma, currently r…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers
This document outlines a Canadian prospective protocol to evaluate biomarkers for hepatocellular carcinoma surveillance in patients with cir…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma [Phase 2]
This clinical trial listing describes a Phase 2 neoadjuvant study of donafenib combined with sintilimab and hepatic arterial infusion chemot…
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. [Phase 1]
Phase 1 trial update for YE-NEO-001, NantBioScience's personalized neoepitope yeast vaccine, evaluating adjuvant immunotherapy to elicit T-c…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients [Phase 2]
A Phase 2 clinical trial is evaluating sequential or upfront triple therapy with durvalumab, tremelimumab, and bevacizumab for non-resectabl…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating hepatic arterial infusion chemotherapy in combination with Adebrelimab and Bevacizumab for potentially res…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy [NA]
A clinical trial registry entry indicates ongoing recruitment for a study on transcutaneous electrical acupoint stimulation (TEAS) to manage…
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab [Phase 2]
A Phase 2 trial is investigating adjuvant treatment with donafenib in combination with envafolimab for patients with a high risk of recurren…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Donafenib Combined With Immunotherapy and Local Therapy for Unresectable Hepatocellular Carcinoma That Has Failed in Previous Therapy [Phase 4]
A Phase 4 clinical trial is planned to evaluate donafenib in combination with immunotherapy and local therapy for unresectable hepatocellula…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma. [Phase 2]
Phase 2 trial investigating neoadjuvant intra-tumor double immunotherapy for hepatocellular carcinoma, currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma [NA]
Clinical trial update evaluating safety and efficacy of selective intra-arterial Holmium-166 radiation therapy in combination with atezolizu…
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors [NA]
This clinical trial assesses the combination of transarterial chemoembolization (TACE) with immune checkpoint inhibitors for non-resectable …